Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
Recruiting now NCT04526093
Run by University Health Network, Toronto · for 19 and older · All sexes
What this study is about
This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.
Who can join (things the study team will check)
✅ You may be able to join if…
- Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
- Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
- Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study
🚫 You may not be able to join if…
- Concomitant use of illicit drugs
- Concomitant use of recreational cannabis
Where this trial is running
- Toronto General Hospital, UHN, Toronto, Ontario, Canada
Who to contact
Sonal Thaker · 416-340-4800 X 4251 · sonalben.thaker@uhn.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT04526093.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.